RxDoctor Payments DataLook up a doctor →

Henry Kwong, MD

Retina Specialist · Phoenix, AZNPI 1033257746

Payments from drug & device makers

$3,399,190in general payments, 2019–2025

Across 879 payments — averaging $3867.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$1.7M
  • Ocular Therapeutix, Inc.$443K
  • Boehringer Ingelheim$409K
  • AstraZeneca$402K
  • Roche TCRC, Inc.$207K
  • US Retina LLC$119K
  • plus $124K from 29 others
$17,955in research payments, 2019–2025

Across 2 payments — averaging $8977.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ocular Therapeutix, Inc.$12K
  • F. Hoffmann-la Roche AG$6K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,399,190 in reported general payments places this provider in the 95th percentile of 30 retina specialist providers in Arizona.

See all retina specialist providers in Arizona

Medicare billing

Part B allowed, 2024
$2,158,536
Medicare patients
1,340
Services billed
15,450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other retina specialist in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →